Home›Compare›MangoRx vs Viking Man

MangoRx vs Viking Man: Which Is Better?

Head-to-head comparison of MangoRx and Viking Man based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MangoRx scores higher overall in our independent evaluation (58/100 vs 55.8/100), leading on trust & safety, experience, product range. Viking Man comes out ahead on value, reputation. Viking Man has the lower entry price (from $20/mo vs $50/mo), so the better value depends on which treatment you need.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx

Viking Man is a Draper, Utah men's telehealth clinic offering low-cost generic ED medication, premature-ejaculation, hair-loss and sleep treatment, and compounded at-home NAD+ injections.

Visit Viking Man

Score Breakdown

DimensionMangoRxViking Man
Overall Score58/100 ✓55.8/100
Trust & Safety30%55/100 ✓52/100
Value25%62/10066/100 ✓
Experience20%58/100 ✓50/100
Product Range15%66/100 ✓58/100
Reputation10%45/10050/100 ✓

At a Glance

Founded20212019
HeadquartersDallas, TXDraper, UT
Publicly tradedYes (MGRX)No
Treatment categories54
Treatments listed54
Starting price$50/mo$20/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxViking Man
Men's Health——
Sexual Health$59–$75
Mango ED (sildenafil or tadalafil)
$20–$60
Generic Sildenafil
Hair Loss$50–$80
Grow (compounded hair-loss formula)
—

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Viking Man

+Generic sildenafil advertised at about $2 per dose, among the lowest ED prices in telehealth
+Low $5 online visit fee with free shipping and unlimited provider messaging
+Covers less common men's issues (premature ejaculation, sleep) alongside ED, hair loss and NAD+
−NAD+ landing page uses manufactured urgency ('82 packs sold in last hour', stock counters) and unsupported weight-loss claims
−Trustpilot reports of repeated automatic charges after shipments were paused in the patient portal
−Almost no independent review footprint (3 Trustpilot reviews, none in the last 12 months)
Read the full Viking Man review →

MangoRx vs Viking Man — FAQ

Is MangoRx better than Viking Man?

▾

MangoRx scores higher overall in our independent evaluation (58/100 vs 55.8/100), leading on trust & safety, experience, product range. Viking Man comes out ahead on value, reputation. Viking Man has the lower entry price (from $20/mo vs $50/mo), so the better value depends on which treatment you need.

Is MangoRx or Viking Man cheaper?

▾

Viking Man has the lower starting price (from $20/mo vs $50/mo for MangoRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Viking Man both offer?

▾

Both platforms treat Men's Health, Sexual Health, Hair Loss. MangoRx covers 5 treatment categories total and Viking Man covers 4.

Still deciding?